Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2000
11/14/2000US6147114 Highly water-soluble metalloproteinase inhibitors
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147077 2R,4S-hydroxyitraconazole isomers
11/14/2000US6147062 Phosphoryl hydrazine insecticides
11/14/2000US6147061 Antiarthritic agents; anticancer agents; oral diseases
11/09/2000WO2000066760A1 Method for producing l-phosphinothricine by enzymatic transamination with aspartate
11/09/2000WO2000066599A1 Antioxidative vitamin b6 analogs
11/09/2000WO2000066598A1 Improved preparations of thiophosphites and thiophosphonates
11/09/2000WO2000066597A1 Ionic liquids and production and use thereof
11/09/2000WO2000066571A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066550A1 New compounds
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066489A1 Synthesis of hydrogen peroxide
11/09/2000WO2000066124A1 Preventive or inhibitory agents for hepatopathy
11/09/2000WO2000066100A2 2r,4s-hydroxyitraconazole isomers
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000030688A3 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/09/2000DE19920847A1 Pd- und Ni-Komplexe von Biphenyl-2-yl-phosphanen und ihre Anwendung in katalytischen C,C-,N- und C,O-Kupplungen Pd and Ni complexes of biphenyl-2-yl-phosphines and their application in catalytic C, C-, N- and C, O-couplings
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000CA2371653A1 Antioxidative vitamin b6 analogs
11/09/2000CA2371215A1 New compounds
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369357A1 2r,4s-hydroxyitraconazole isomers
11/09/2000CA2336605A1 Improved preparations of thiophosphites and thiophosphonates
11/08/2000EP1050537A2 Phosphinoxide vitamin d precursors
11/08/2000EP1049759A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
11/08/2000EP1049695A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
11/08/2000EP1049682A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation
11/08/2000CN1272847A Method for producing phosphabenzene compounds
11/08/2000CN1272499A Method for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide
11/08/2000CN1058294C Method for preparation of compound named 'Leustroducsins'
11/08/2000CN1058266C 14-substituted marcfortines and derivatives useful as antiparasitic agents and its application
11/07/2000US6143929 Comprising reacting an o-alkylisourea salt and a primary or secondary amine in the presence of crystals of a guanidine derivative
11/07/2000US6143923 Introducing phosphorus trihalide into a reactor containing aqueous acid at a temperature of 60-200 degrees c and a pressure of 15-150 psig, adding water to hydrolyze the intermediate formed
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143847 Such as methacrylate polymers of narrow molecular weight distribution
11/07/2000US6143834 Optically active phosphine derivative having at least two vinyl groups, polymer produced using the same as monomer, and transition metal complexes of these
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143733 Drugs for central nervous system diseases such as parkinson's disease, alzheimer's disease, huntington chorea, amyotrophic lateral sclerosis and olivopontocerebellar degeneration, psychiatric diseases such as anxiety conditions, migraine
11/07/2000US6143732 Used as antiviral agent against influenza virus
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000US6143274 Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
11/07/2000CA2039724C Method of preparing monothiophosphoric acid by sulfurizing a phosphite in the presence of an amide
11/02/2000WO2000065099A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof
11/02/2000WO2000065002A1 Non-symmetric, partially fluorinated lubricant additives
11/02/2000WO2000064914A1 Bidentate organophosphorous ligands and their use
11/02/2000WO2000064913A1 Method for producing sulfonated aryl phosphines
11/02/2000WO2000064912A1 Phosphoric benzoyl derivatives and their use as herbicides
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064910A1 Stable solutions of rare earth tris (organophosphorus-derivatives)
11/02/2000WO2000064848A1 Method for the dihydroxylation of olefins using transition-metal catalysts
11/02/2000WO2000064841A2 Phosphine ligands, metal complexes and compositions thereof for cross-coupling reactions
11/02/2000WO2000037464A3 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
11/02/2000EP1047705A2 Nucleobase oligomers
11/02/2000EP1047701A1 Mitochondrially targeted antioxidants
11/02/2000EP1047700A1 Method for producing salts of dialkylphosphinic acids
11/02/2000EP1047693A1 Herbicides 3-(benzazol-4-yl)pyrimidine-dione-derivatives
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047677A2 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents
11/02/2000EP1047669A1 Perfluoro-n-alkylsulfonic acid derivatives
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
11/02/2000DE19919848A1 Verfahren zur Herstellung von L-Phosphinothricin durch enzymatische Transaminierung mit Aspartat A process for preparing L-phosphinothricin by enzymatic transamination with aspartate
11/02/2000DE19919494A1 Ionische Flüssigkeiten, ihre Herstellung und ihre Verwendung Ionic liquids, their preparation and their use
11/02/2000CA2372500A1 Phosphoric benzoyl derivatives and their use as herbicides
11/02/2000CA2371183A1 Method for the dihydroxylation of olefins using transition-metal catalysts
11/02/2000CA2367594A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof
11/01/2000CN1058017C Intermediate for prepariny etoposide
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1057975C Phosphation reagent composition and its use
10/2000
10/31/2000US6140537 Process for producing boron compounds
10/31/2000US6140519 Does not use acetone as a solvent, thereby yielding an acetone-free product suitable for animal or human consumption
10/31/2000US6140495 Chemiluminescent 1,2-dioxetanes
10/31/2000US6140460 Bidentate phosphine ligand having at least two phosphorus atoms joined by a bridging group containing nitrogen and optionally phosphorus atoms
10/31/2000US6140398 Reaction product of phosphoryl compound selected from phenylphosphonic dichloride and a phosphorus oxy halide, a straight, branched or cyclic alkyl or aromatic ester of salicylic acid, and an organic dihydroxy compound
10/31/2000US6140310 Phosphorous prodrugs
10/31/2000US6140273 Herbicides; made by reacting a cyclohexane-1,3-dione with an activated benzoic acid or benzoic acid compound, to give an acylation product, and subsequent rearrangement
10/31/2000US6140265 Catalyst for cross-coupling reactions
10/31/2000US6140051 Fluorescent dibenzazole derivatives and methods related thereto
10/31/2000US6139782 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
10/31/2000US6139781 Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
10/26/2000WO2000063991A1 Phosphorus atom containing fluorinated cationic exchange membrane and proton-conductive fuel cell
10/26/2000WO2000063195A1 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
10/26/2000WO2000063171A1 Tricyclic compounds
10/26/2000WO2000062711A1 Intravascular stent and method of treating neurovascualr vessel lesion
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000DE19920038A1 Preparation of 1,2-diols, used e.g. as a solvent or intermediate for polymers, agrochemicals, cosmetics and pharmaceuticals, by hydroxylation of an olefin in the presence of oxygen and an osmium, ruthenium or manganese compound
10/26/2000DE19918420A1 New bidentate organophosphorus ligands whose transition metal complexes are useful as catalysts for polymerization and asymmetric synthesis comprise a trivalent phosphine group and another trivalent phosphorus group
10/26/2000DE10014532A1 New N-acyl-phosphoryl triamide derivatives, useful as urease inhibitors, e.g. to prevent nitrogen loss from urea fertilizers
10/25/2000EP1046647A2 Group 8,9 or 10 transition metal catalyst for olefin polymerization
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1045897A1 Enzyme catalyzed therapeutic agents
10/25/2000EP1045854A1 Preparation of phosphonic acid derivatives
10/25/2000EP1045853A1 Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045689A1 Synthesis of phenstatin and prodrugs thereof
10/25/2000CN1271356A Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for corresponding antifungal agent
10/25/2000CN1271289A Osteoblast-specific mitogens and drugs containing such compounds
10/24/2000US6137012 Phosphole and diphosphole ligands for catalysis